Cempra, Inc. (CEMP)

[Johnny_C]

SEC docs being filed. They are long and some over 200 pages.

So, if you can believe these dumbarse numnuts, the filings state

Cemp valued at 500 million

New Company 520 million

Cemp gets 48% New Company 52%


Without synergies this would put the stock at $9.00 valuation..


That is of course, if you believe the valuations..

As far as Cemp, the FDA break is a bit misleading. The trial size has been cut down but the intravenous indication has been removed. Oral is easier for approval, but intravenous would be from extremely sick patients in hospitals and would be a higher price point.

Oral would still be a second line antibiotic behind a generic.